The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle
Open accessAbstract
The broad nature of insulin resistant glucose metabolism in skeletal muscle of patients with type 2 diabetes suggests a defect in the proximal part of the insulin signaling network. We sought to identify the pathways compromised in insulin resistance and to test the effect of moderate exercise on whole-body and cellular insulin action. We conducted euglycemic clamps and muscle biopsies on type 2 diabetic patients, obese nondiabetics and lean controls, with and without a single bout of exercise. Insulin stimulation of the phosphatidylinositol 3-kinase (PI 3-kinase) pathway, as measured by phosphorylation of the insulin receptor and IRS-1 and by IRS protein association with p85 and with PI 3-kinase, was dramatically reduced in obese nondiabetics and virtually absent in type 2 diabetic patients. Insulin stimulation of the MAP kinase pathway was normal in obese and diabetic subjects. Insulin stimulation of glucose-disposal correlated with association of p85 with IRS-1. Exercise 24 hours before the euglycemic clamp increased phosphorylation of insulin receptor and IRS-1 in obese and diabetic subjects but did not increase glucose uptake or PI 3-kinase association with IRS-1 upon insulin stimulation. Thus, insulin resistance differentially affects the PI 3-kinase and MAP kinase signaling pathways, and insulin-stimulated IRS-1-association with PI 3-kinase defines a key step in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using the euglycemic insulin clamp with skeletal muscle biopsy, a number of investigators have examined the insulin signal transduction system in human skeletal muscle of type 2 diabetic subjects and consistently demonstrated defects in IRS-1 tyrosine phosphorylation and PI-3 kinase and Akt activation ( 26 , 54 , 55 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [54]
Experimental — accuracy not yet measuredIn the citing paper
“In contrast, as the MAPK pathway has normal sensitivity to insulin, hyperinsulinemia activates the MAPK pathway, promoting vascular smooth muscle cell growth and activating inflammatory pathways, such as IkB/NF-kB and JNK [107,108].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [107]
In the citing paper
“Insulin resistance in skeletal muscle is manifested by decreased insulin-stimulated glucose uptake and results from impaired insulin signaling and multiple post-receptor intracellular defects including impaired glucose transport, glucose phosphorylation, and reduced glucose oxidation and glycogen synthesis.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Association of the p85 subunit of PI3K with IRS-1 and activation of PI3K also are greatly attenuated in obese nondiabetic and type 2 diabetic subjects compared with lean healthy controls [7, 165, 166].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“The ability of insulin to activate insulin receptor and IRS-1 tyrosine phosphorylation in muscle in obese nondiabetic subjects is modestly reduced; whereas in type 2 diabetics insulin-stimulated insulin receptor and IRS-1 tyrosine phosphorylation are severely impaired [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Most [1, 7, 152, 153, 156, 161] but not all [155] investigators have found a reduction in tyrosine kinase activity that cannot be explained by alterations in insulin receptor number or insulin receptor binding affinity.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“In insulin-resistant obese nondiabetic subjects, in the NGT insulin resistant offspring of two diabetic parents, and in type 2 diabetic subjects, a substantial decrease in insulin receptor tyrosine phosphorylation has been demonstrated.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“The decrease in insulin-stimulated association of the p85 regulatory subunit of PI3K with IRS-1 is closely correlated with the reduction in insulin-stimulated muscle glycogen synthase activity and in vivo insulin-stimulated glucose disposal [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Intact stimulation of the MAPK pathway by insulin in the presence of insulin resistance in the PI3K pathway may play an important role in the development of atherosclerosis [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Insulin resistance in the PI3K signaling pathway contrasts with an intact stimulation of the MAPK pathway by insulin in insulin-resistant type 2 diabetic and obese nondiabetics individuals [7, 165].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Under basal conditions, total glycogen synthase activity in type 2 diabetic subjects is reduced, and the ability of insulin to activate glycogen synthase is severely impaired [7, 215–217].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252
Self-citationCheatham, B., Vlahos, C. J., Cheatham, L. A., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902-4911.1994 · Cited by 1,062
Self-citationMeasurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Perseghin, G., Price, T. B., Petersen, K. F., Roden, M., Cline, G. W., Gerow, K., Rothman, D. L., & Shulman, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351804 · Cited by 699
Jiang, Z. Y., Lin, Y.-W., Clemont, A., Feener, E. P., Hein, K. D., Igarashi, M., Yamauchi, T., White, M. F., & King, G. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5971 · Cited by 604
Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561
Effect of physical exercise on sensitivity and responsiveness to insulin in humans
Mikines, K. J., Sonne, B., Farrell, P. A., Tronier, B., & Galbo, H. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.254.3.e248 · Cited by 538
Goodyear, L. J., Giorgino, F., Sherman, L., Carey, J., Smith, R. J., & Dohm, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117909 · Cited by 527
Ren, J., Semenkovich, C. F., Gulve, E. A., Gao, J. H., & Holloszy, J. O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36636-x · Cited by 416
Research works printed but not linked: 9
- Cheatham, 1994, Mol Cell Biol, 14, 4902, 10.1128/MCB.14.7.4902 · DOI
- Nyomba, 1990, Am J Physiol, 258, E964
- Hayashi, 1997, Am J Physiol, 273, E1039
- Koval, 1998, Am J Physiol, 274, E304
- O’Doherty, 1994, Am J Physiol, 266, E171
- Mikines, 1988, Am J Physiol, 254, E248
- Goodyear, 1995, Am J Physiol, 268, E987
- Zorzano, 1986, Am J Physiol, 251, E664
- Kochan, 1979, Am J Physiol, 236, E660
Cited by
Sorted by citations
Items 901–997 of 997
Habtemariam, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102922-0.00012-2 · Cited by 2
Insulin Resistance and Cardiometabolic Syndrome
Kim, J. (2021) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2021.1.e9 · Cited by 3
Mitochondrial dysfunction in metabolic disorders
Advani, D., Sharma, S., Tripathi, R. S., Gupta, R. V., Jaiswal, A., Ambasta, R. K., & Kumar, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85666-9.00015-2 · Cited by 3
Cellular Mechanisms of Insulin Action
Ciaraldi, T. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_5 · Cited by 2
Insulin Resistance and Atherosclerosis
Singh, K., & Raghavan, V. A. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_3 · Cited by 2
Petunina, N. A., Валерьевна, Г. Е., Кузина, И. А., Недосугова, Л. В., Степановна, М. Н., & Эдуардовна, Т. М. (2022) · Diabetes Mellitus · doi:10.14341/dm12859 · Cited by 3
Kuznetsova, L. A., & Basova, N. E. (2022) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2022-7.6.6 · Cited by 2
Genetic and Epigenetics of Type 2 Diabetes
Coletta, D. K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.02002-5 · Cited by 2
Barbato, G. M., Cadamuro, M., & Fabris, L. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.01.009 · Cited by 2
FULMINANT MYOCARDITIS-A UNIQUE COMPLICATION OF COVID-19
Ahmed, A., Young, S. K., & Lantz, R. H. (2021) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(21)03378-7 · Cited by 2
Jonk, A. M. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20111215aj · Cited by 2
Adipose Tissue and Blood Pressure Regulation
Cassis, L. A., & Police, S. B. (2010) · Wiley eBooks · doi:10.1002/9783527629527.ch13 · Cited by 2
Combination therapy in type 2 diabetes mellitus
Abdul‐Ghani, M. A., DeFronzo, R. A., & Eldor, R. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch46 · Cited by 2
Self-citationBlunted Coronary Vasoreactivity to Insulin Is an Early Alteration in Hypertension
Sundell, J., Laine, H. K., Luotolahti, M., Nuutila, P., Kalliokoski, K. K., Raitakari, O. T., & Knuuti, J. M. (2003) · Journal of Vascular Research · doi:10.1159/000068939 · Cited by 2
Staels, B. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)81731-7 · Cited by 2
Cardiovascular Disease and Insulin Resistance
Ajjan, R., & Grant, P. J. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_138 · Cited by 2
Tchaikovski, V., & Waltenberger, J. L. (2007) · Springer eBooks · doi:10.1007/1-4020-5955-8_3 · Cited by 2
Han, X., Møller, L. L. V., Groote, E. D., Bojsen-Møller, K. N., Davey, J., Henríquez-Olguin, C., Li, Z., Knudsen, J. R., Jensen, T. E., Madsbad, S., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/568097 · Cited by 4
Kaviyani, N., Keshavarz, S. A., & Abbasi, B. (2020) · doi:10.21203/rs.3.rs-37045/v1 · Cited by 2
Exercise therapy in Type 2 Diabetes
Praet, S. (2007) · Research Publications (Maastricht University) · doi:10.26481/dis.20071214sp · Cited by 3
Mattsson, N. (2012) · UTUPub (University of Turku) · Cited by 2
Evaluation of endothelial function in obese children and adolescents
Arsoy, H. E. M., Ergür, A. T., & Kaan, A. G. (2021) · Annals of Clinical Endocrinology and Metabolism · doi:10.29328/journal.acem.1001019 · Cited by 1
Ouassou, H., Daoudi, N. E., Bouknana, S., Abdnim, R., & Bnouham, M. (2024) · Medicinal Chemistry · doi:10.2174/0115734064255060231116192839 · Cited by 2
Yakupova, E. I., & Popov, D. V. (2024) · Genes and Cells · doi:10.17816/gc630891 · Cited by 1
Type 2 Diabetes and Concomitant Illness
Dungan, K. M., Harris, E., & Braithwaite, S. S. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_14 · Cited by 1
Williams, M. E., & Stanton, R. C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00031-x · Cited by 1
The effect of 10- versus 30-minutes of acute aerobic exercise on insulin and glucose in obese adults
Mishler, A. E. (2012) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Javanmard, S. H., Nematbakhsh, M., Feghhi, A., & Dana, N. (2012) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-11-5 · Cited by 1
Cersósimo, E., Xu, X., Upala, S., Triplitt, C. L., & Musi, N. (2014) · Cited by 1
Milder forms of obesity may be a good evolutionary adaptation: 'Fitness First' hypothesis
Rakesh, T. P., & Syam, T. P. (2015) · Hypothesis · doi:10.5779/hypothesis.v10i1.388 · Cited by 1
Anabolic signalling in skeletal muscle : impact of diet and disease
Gran, P. (2011) · Cited by 1
Green, D. E. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-0273-4.50027-8 · Cited by 1
Metabolic and Cardiovascular Effects of Exercise in the Adult With Diabetes
Todd, C. W. (2010) · Orthopaedic Section, APTA, Inc. eBooks · doi:10.17832/isc.2010.20.1.3 · Cited by 1
Colette, C., & Monnier, L. (2012) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(12)70355-3 · Cited by 1
The Endothelial Barrier Is not Rate-limiting to Insulin Action in the Myocardium of Male Mice
Sanwal, R., Khosraviani, N., Advani, S. L., Advani, A., & Lee, W. L. (2020) · Endocrinology · doi:10.1210/endocr/bqaa029 · Cited by 1
Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
Carreau, A., Battista, M., & Baillargeon, J. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_8 · Cited by 1
Yilmaz, B. A., & Törüner, F. B. (2013) · CRC Press eBooks · doi:10.1201/b14907-9 · Cited by 1
Bashir, M. I., Wani, A. I., & Masoodi, S. R. (2011) · J Med Sci · doi:10.33883/jms.v14i1.62 · Cited by 1
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.1.1.37 · Cited by 1
Ren, L., Ju, F., Liu, S. J., Cai, Y., Gang, X., & Wang, G. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s476815 · Cited by 4
Prevention of Hyperglycemic Signal Pathways in Metabolic Syndrome Carotid Artery of Rats
Kawai, H., Tian, F., Kurata, T., Deguchi, K., Yamashita, T., Omote, Y., Kono, S., & Abe, K. (2012) · Translational Stroke Research · doi:10.1007/s12975-012-0205-6 · Cited by 1
Prediabetes - The New Target for Primary Prevention of Cardiovascular Metabolic Dysfunction
Afzan, E., Ahmad, R., Lim, B. T. X., Amudha, K., Hussain, R., Azman, W., Ahmad, W., Ismail, I. S., Choy, A. M., & Lang, C. C. (2005) · Cited by 1
Síndrome metabólico: enfoque fisiopatológico
Duque, O. A. P., Zapata, D. F. L., & Trujillo, J. C. G. (2015) · Areandina · doi:10.33132/01248146.544 · Cited by 1
Assessment of human lymphocyte proliferation associated with metabolic syndrome
Duque, O. A. P., Sánchez, J. C., Arias, J. C., & Zapata, D. F. L. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0307-6 · Cited by 1
Mechanisms of Action of Drugs for Treating Endothelial Dysfunction in Diabetes Mellitus
Nizami, H. L., & Banerjee, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-60324-7_22 · Cited by 1
Relationship between type 2 diabetes and pancreatic cancer
Yilmaz, M. T., & Gürol, A. O. (2018) · Translational Medicine Reports · doi:10.4081/tmr.7002 · Cited by 1
Bourey, R. E., Kaw, M., Lester, S. G., Ghanem, S. S., & Najjar, S. M. (2014) · CRC Press eBooks · doi:10.1201/b16783-4 · Cited by 1
Glucose and lipid metabolism in human skeletal muscle
Skrobuk, P. (2012) · Työväentutkimus Vuosikirja · Cited by 1
Insulin and Insulin‐Like Growth Factor
Levine, T., & Levine, A. (2012) · Wiley eBooks · doi:10.1002/9781118480045.ch5 · Cited by 1
Endothelial Vasodilatory Dysfunction in Hypertension
Campia, U., & Panza, J. A. (2007) · Wiley eBooks · doi:10.1002/9780470988473.ch15 · Cited by 1
Molecular mechanisms and modulation of endothelial progenitor cell function in South Asian men
Baliga, V. (2012) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Insulin Resistance and Inhibitors of the Insulin Receptor Tyrosine Kinase
YOUNGREN, J. F. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_15 · Cited by 1
Evidence for the down-regulation of ATP6V1H gene expression in type 2 diabetes
Molina, M. F. (2017) · Texas ScholarWorks (Texas Digital Library) · doi:10.15781/t2v98071k · Cited by 1
Hill, C. A. (2010) · SUNScholar (Stellenbosch University) · Cited by 1
Insulin signalling in human adipocytes mechanisms of insulin resistance in type 2 diabetes
Danielsson, A. (2007) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
The role of CADM1 in energy and glucose homeostasis
Matthäus, D. (2014) · doi:10.18452/16905 · Cited by 1
Farhat, G. (2014) · Queen Margaret University Publications Repository (Queen Margaret University) · Cited by 1
La régulation du métabolisme du glucose par la protéine tyrosine phosphatase SHP-1
Bergeron, S. (2007) · Corpus Université Laval (Université Laval) · Cited by 1
Smith, W. T. (2006) · SUNScholar (Stellenbosch University) · Cited by 1
Monroy, A., Gómez-Laguna, L., Aranda-Flores, C. E., & Alavez, S. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_147 · Cited by 1
The 6th Annual World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2009) · Diabetes Care · doi:10.2337/dc09-zb10 · Cited by 1
DeFronzo, R. A., & Mandarino, L. J. (2003) · Encyclopedia of Hormones · doi:10.1016/b0-12-341103-3/00176-5 · Cited by 1
Self-citationThe Importance of Exercise in Patients with Diabetes
Tantiwong, P., & Musi, N. (2024) · Maharat Nakhon Ratchasima Hospital Journal · Cited by 1
Exercise as an Effective Treatment for Type 2 Diabetes
Consitt, L. A., Boyle, K. E., & Houmard, J. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_9 · Cited by 1
The influence of antioxidants on thrombotic risk factors in healthy population
Singh, I. (2010) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27332532
Korsheninnikova, E. (2003) · Työväentutkimus Vuosikirja
Resistencia a la insulina sin síndrome metabólico: ¿cuáles son sus implicaciones cardiometabólicas?
Madrigal, J. C., & Correa, S. M. L. (2009) · Medicina Interna de México
Role of immune mediators in metabolic syndrome and atherosclerosis
Strodthoff, D. (2013) · Figshare
The Molecular Basis of Insulin Action and Insulin Resistance
Avruch, J. (2001) · Endocrine updates · doi:10.1007/978-1-4615-1597-5_8
Fraser, A. (2005) · Research Online (University of Wollongong)
de Queiroz, J. F. (2008) · Americanae (AECID Library)
Suplementação crônica de leucina não impede a condição pró-inflamatória do destreinamento físico
Neto, E. M. D. M. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2011.tde-22122011-085542
Glund, S. (2007) · Figshare
Leptin and insulin as adiposity signals
Niswender, K. D. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541643.005
Endothelial Dysfunction in the Metabolic Syndrome
Avogaro, A. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50019-x
Insulina, hipertensión y diabetes
Briceño, S., & Silva, E. (2007) · Redalyc (Universidad Autónoma del Estado de México)
Gatenby, V. K. (2014) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
The Endothelium, Cardiovascular Disease, and Therapy
Levine, T. B., & Levine, A. B. (2012) · Wiley eBooks · doi:10.1002/9781118480045.ch14
Regulation of hepatic lipogenesis by the transcription complex Prep1-Pbx1
Cabaro, S. (2011) · Università degli Studi di Napoli Federico II · doi:10.6092/unina/fedoa/8811
Neural mechanisms of sympathetic activation during hyperinsulinemia and obesity-induced hypertension
Bardgett, M. E. (2010) · UKnowledge (University of Kentucky)
Insulin Resistance, Metabolic Syndrome, and Therapy
Levine, T. B., & Levine, A. B. (2012) · Wiley eBooks · doi:10.1002/9781118480045.ch15
Overlaps Between the Insulin and IGF-I Receptor and Cancer
Belfiore, A., & Malaguarnera, R. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0598-6_14
Yang, Z. (2014) · Human Biology
LIVER FAT IN THE METABOLIC SYNDROME AND TYPE 2 DIABETES
Kotronen, A. (2008) · Työväentutkimus Vuosikirja
Essential Fatty Acid Metabolism in Metabolic Syndrome and Neurological Disorders
Farooqui, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7318-3_3
Endothelin-1 in the regulation of vascular function and glucose metabolism in insulin resistance
Shemyakin, A. S. (2010) · Figshare
Nyman, E. (2014) · Linköping University Electronic Press eBooks · doi:10.3384/diss.diva-104725
Influence of protein nutrition and exercise on muscle metabolism.
Breen, L. (2011) · University of Birmingham Institutional Research Archive (University of Birmingham)
Mashili, F. L. (2012) · Figshare
GRK2-Deficiency Reduces Insulin Activation of ERK1/2 and Mitogenesis in Mouse Liver FL83B Cells
Shahid, G., & Hussain, T. (2009) · The Open Diabetes Journal · doi:10.2174/1876524600902010044
Asubonteng, J. O. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Metadata
- Authors
- Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Harvard University (US)
- Tulane University (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Mandarino, Lawrence J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2000-02-01
- Volume
- 105
- Issue
- 3
- Pages
- 311-320
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC377440
- OpenAlex
- W2120852510
- Cited by
- 1,139
- References
- 48
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 19 · 2023: 27 · 2022: 35 · 2021: 45 · 2020: 33 · 2019: 35 · 2018: 24 · 2017: 37 · 2016: 52 · 2015: 54 · 2014: 53 · 2013: 57 · 2012: 65
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (5k08dk002526-03)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-24092, DK02526, R01DK047936, R01DK033201, R01DK024092, R01-DK-47936)
- National Center for Research Resources (M01RR001346)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- insulin resistance, skeletal muscle, type 2 diabetes, PI3K signaling, MAPK signaling, insulin receptor, IRS-1, p85 regulatory subunit, physical activity, glucose uptake, obesity, euglycemic clamp, insulin signaling
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Phosphoproteins, Receptor, Insulin, Signal Transduction, Muscle, Skeletal, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinases, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
